Mushroom and Botanical Immune Capsules

Five Mushroom Extracts Are Named in the Current Record

Reishi is listed at 200 mg. Chaga, maitake, shiitake and Agaricus blazei are each listed at 100 mg. Those five names define the present facts summary and should match the commercial master formula.

A custom version may add another mushroom only as a documented formula change. The new species needs an approved identity, amount, supplier specification and testing plan before it is placed on the packaging.

Confirm the Fungal Part and Extract Specification

The current record identifies reishi as a fruiting-body extract. It does not provide the same part detail for chaga, maitake, shiitake or Agaricus blazei. Supplier specifications should state the accepted scientific identity, fungal part, extraction process, assay and carrier for each material.

No beta-glucan or polysaccharide percentage is present in the supplied facts. Do not promote a standardized mushroom complex or compare potency by species count until the selected ingredients and test methods support that wording.

Echinacea Is the Largest Listed Input

Echinacea aerial-parts extract contributes 400 mg, which exceeds every individual mushroom amount. Astragalus root extract adds 100 mg with at least 1% astragaloside, and zinc contributes 15 mg. The formula is therefore a botanical and mushroom hybrid, not a pure mushroom capsule.

That hierarchy should remain visible in the commercial brief. Calling every ingredient a hero would obscure the actual formula and make it look like the general echinacea product. Here, the buying decision centres on documented mushroom materials within a broader botanical blend.

Two Capsule Feasibility Needs a Fill Trial

The listed extracts carry a substantial combined input before zinc compound weight and excipients. Mushroom powders can also differ in bulk density, flow and moisture behaviour. A pilot run should confirm shell size, target fill, weight control and capsule closure.

Changing one extract grade can alter the physical blend even when the label amount stays the same. The final cost and process plan should therefore use approved commercial samples rather than a generic mushroom powder assumption.

Difference from a Probiotic Mushroom Formula

HEKONA also has a probiotic-led mushroom capsule. That project requires strain identity, CFU timing and moisture protection. This formula contains no probiotic in the current facts and belongs with immune support products.

The two concepts can be compared by internal links, but their technical requirements should remain separate. Buyers can then choose between a botanical mushroom system and a probiotic formula without reading interchangeable benefit claims.

Before Quotation

There is no ready-stock designation for this SKU. HEKONA can quote the project after the mushroom count, raw-material specifications, destination market, serving format and final pack are confirmed.

Provide the target country, required fungal parts or assays, capsule shell, bottle count, claim direction and expected volume. The response can then cover material options, fill trials, finished testing, packaging, MOQ and production timing without guessing.

Buyer Questions

How many mushroom extracts are in the current facts

Five are named: reishi, chaga, maitake, shiitake and Agaricus blazei. The master formula and final artwork must confirm the definitive count.

Are the mushroom extracts standardized for beta glucans

No such percentage appears in the current facts. Use a beta-glucan claim only after the approved supplier specification and test method support it.

Can the formula be made as one capsule

That cannot be assumed from label weights. Commercial material samples and a fill trial are needed before reducing the serving.

Confirm a Mushroom Botanical Capsule Brief

Send the approved mushroom list, fungal-part and assay requirements, destination market, capsule format, pack count and expected volume. HEKONA will review feasibility and quote only after the formula record is reconciled.